GENEPHARM AMLODIPINE amlodipine 2.5 mg (as besilate) tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

amlodipine besilate, Quantity: 3.5 mg

Disponible desde:

Arrotex Pharmaceuticals Pty Ltd

Designación común internacional (DCI):

amlodipine besilate

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: lactose monohydrate; magnesium stearate; maize starch; microcrystalline cellulose

Vía de administración:

Oral

Unidades en paquete:

30 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Hypertension - Genepharm Amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of Genepharm Amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. Angina - Genepharm Amlodipine is indicated for the first line treatment of chronic stable angina. Genepharm Amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

Resumen del producto:

Visual Identification: white to off white, round, unscored tablets, engraved "APO" on one side and "AML" over "2.5" on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2007-12-13